Internal Medicine

3151 questions

Question 2941Question →

During morning rounds in the medical intensive care unit, a physician evaluates a patient admitted for severe hypovolemia secondary to intractable diarrhea.

The patient, a 5555-year-old male, reports four days of unremitting watery stools. Intravenous fluid resuscitation is planned but has not yet been initiated. Vital signs show a blood pressure of 90/60 mm Hg90/60\text{ mm Hg} and a heart rate of 110/min110/\text{min}. Physical examination is notable for poor skin turgor, delayed capillary refill, and dry oral mucosa. Laboratory analysis of blood and urine samples obtained simultaneously reveals the following values:

ParameterValue
Serum sodium135 mEq/L135\text{ mEq/L}
Serum creatinine2.7 mg/dL2.7\text{ mg/dL}
Blood urea nitrogen60 mg/dL60\text{ mg/dL}
Urine sodium27 mEq/L27\text{ mEq/L}
Urine creatinine135 mg/dL135\text{ mg/dL}

Based on these findings, what is the patient's calculated fractional excretion of sodium (in percent)?

Show answer & explanation

Answer: 0.4

Answer

The fractional excretion of sodium (FENa) is 0.4%.
The patient's clinical presentation (intractable diarrhea, hypotension, tachycardia, dry mucous membranes) is highly suggestive of prerenal acute kidney injury due to severe volume depletion. This is biochemically supported by calculating the fractional excretion of sodium (FENa), which measures the percentage of filtered sodium that is excreted in the urine. The formula is:

FeNa=UNa×PCrPNa×UCr×100FeNa = \frac{U_{Na} \times P_{Cr}}{P_{Na} \times U_{Cr}} \times 100

Plugging in the patient's values yields:

FeNa=27×2.7135×135×100=72.918225×100=0.4%FeNa = \frac{27 \times 2.7}{135 \times 135} \times 100 = \frac{72.9}{18225} \times 100 = 0.4\%

A FENa of less than 1%1\% indicates intense renal sodium avidity and reabsorption, which is the hallmark of a prerenal etiology as the kidneys attempt to restore intravascular volume. Note that while the absolute urine sodium concentration in this patient is greater than 20 mEq/L20\text{ mEq/L} (a classic but often unreliable indicator of prerenal status), the FENa calculation adjusts for free water reabsorption and accurately unmasks the true prerenal state.

Step-by-Step Solution

1
Identify the formula for the fractional excretion of sodium (FENa).
FeNa = (Urine Na * Serum Cr) / (Serum Na * Urine Cr) * 100
This formula calculates the percentage of filtered sodium that is excreted, which helps differentiate prerenal from intrinsic acute kidney injury.
2
Extract the necessary laboratory values from the clinical vignette.
Urine Na = 27 mEq/L, Serum Cr = 2.7 mg/dL, Serum Na = 135 mEq/L, Urine Cr = 135 mg/dL.
These specific values are required to populate the variables in the FENa equation. Note that Blood Urea Nitrogen (BUN) is not needed for this calculation.
3
Substitute the values into the formula and calculate the numerator and denominator.
Numerator = 27 * 2.7 = 72.9. Denominator = 135 * 135 = 18225.
Simplifying the fraction before final division ensures calculation accuracy.
4
Divide the numerator by the denominator and multiply by 100 to convert to a percentage.
(72.9 / 18225) * 100 = 0.004 * 100 = 0.4%.
This yields the final FENa percentage.

Key Concept

Fractional excretion of sodium (FENa) calculation in the assessment of acute kidney injury
Question 2942Question →

A physician is reviewing several cases of suspected infective endocarditis. The causative microorganisms often have distinct clinical associations based on patient demographics and antecedent procedures. For each patient presentation described below, identify the most probable responsible pathogen.

Click a left item, then click its matching right item

Items

A 32-year-old with a history of injection drug use, presenting with high fever, a tricuspid regurgitation murmur, and cavitary lung lesions.
A 65-year-old with urinary retention who develops a new systolic murmur and fever three weeks following a cystoscopy.
A 48-year-old with severe gingivitis who develops subacute fevers and Osler nodes one month after a deep dental scaling procedure.
A 58-year-old who develops a paravalvular leak and persistent bacteremia one month following mechanical mitral valve replacement.
A 70-year-old presenting with insidious endocarditis who is subsequently diagnosed with asymptomatic ascending colon adenocarcinoma.

Matches

Show answer & explanation

Answer

The correct matches rely on identifying the specific risk factor for each pathogen: injection drug use (Staphylococcus aureus), genitourinary instrumentation (Enterococcus faecalis), dental work (Viridans group streptococci), recent prosthetic valves (Staphylococcus epidermidis), and colonic malignancy (Streptococcus gallolyticus).
Each pathogen presents with distinct epidemiological associations. Staphylococcus aureus causes acute, right-sided endocarditis in IV drug users. Enterococcus faecalis often follows GU tract manipulation. Viridans group streptococci are tied to poor dentition and dental procedures. Staphylococcus epidermidis is the leading cause of early prosthetic valve infections. Streptococcus gallolyticus is highly associated with colonic lesions.

Step-by-Step Solution

1
Identify the primary risk factor or underlying condition in each clinical scenario.
The distinct risk factors provided are: intravenous drug use, genitourinary instrumentation, dental procedure, prosthetic valve presence, and colorectal malignancy.
Endocarditis pathogens have highly specific associations with certain portals of entry and patient demographics.
2
Correlate each risk factor with the normal flora of the affected site or the typical nosocomial exposure.
Skin and IV access correlates with Staphylococcus aureus; GI tract pathology with Streptococcus gallolyticus; oral cavity with Viridans group streptococci; GU tract with Enterococcus faecalis; and surgical hardware with Staphylococcus epidermidis.
Pathogens typically enter the bloodstream through the disruption of mucosal or cutaneous barriers where they naturally colonize.

Key Concept

Infective Endocarditis Microbiology and Risk Factors
Question 2943Question →

An 8282-year-old man arrives at the emergency department accompanied by his daughter due to a 33-day history of progressively worsening difficulty breathing. He states he cannot sleep lying flat and requires three pillows at night. Medical history is significant for coronary artery disease with a previous myocardial infarction, type 2 diabetes mellitus, and severe chronic obstructive pulmonary disease (COPD). His current medications include lisinopril, metoprolol succinate, and a daily tiotropium inhaler.

Vital signs are:
Temperature: 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F})
Blood pressure: 158/92 mm Hg158/92\text{ mm Hg}
Pulse: 115/min115/\text{min}
Respirations: 28/min28/\text{min}
Oxygen saturation: 85%85\% on room air

Physical examination shows a patient in acute respiratory distress using accessory muscles. The jugular venous pressure is distended to 12 cm H2O12\text{ cm H}_2\text{O}. Auscultation of the chest reveals diminished breath sounds with prolonged expiration, diffuse expiratory wheezes, and dullness to percussion at the lung bases. Cardiac examination reveals a regular tachycardia, a normal S1S_1 and S2S_2, and an extra low-frequency heart sound occurring just after S2S_2.

Laboratory and arterial blood gas (room air) results are as follows:

ParameterValueReference Range
B-type natriuretic peptide (BNP)920 pg/mL920\text{ pg/mL}<100 pg/mL<100\text{ pg/mL}
Thyroid-stimulating hormone (TSH)5.1 μU/mL5.1\text{ }\mu\text{U/mL}0.4−4.0 μU/mL0.4-4.0\text{ }\mu\text{U/mL}
Free thyroxine (T4)1.0 ng/dL1.0\text{ ng/dL}0.9−1.7 ng/dL0.9-1.7\text{ ng/dL}
pH7.287.287.35−7.457.35-7.45
pCO2_256 mm Hg56\text{ mm Hg}35−45 mm Hg35-45\text{ mm Hg}
pO2_252 mm Hg52\text{ mm Hg}75−105 mm Hg75-105\text{ mm Hg}
HCO3−_3^-25 mEq/L25\text{ mEq/L}22−28 mEq/L22-28\text{ mEq/L}

A portable chest radiograph displays an enlarged cardiac silhouette, perihilar alveolar opacities, and bilateral blunting of the costophrenic angles. The patient is placed on noninvasive positive-pressure ventilation.

Which of the following is the most appropriate next step in pharmacologic management for this patient?

Show answer & explanation

Answer: Intravenous furosemide administration

Answer

Intravenous furosemide administration
The correct answer is intravenous furosemide administration. This patient presents with acute respiratory distress, orthopnea, an S3 gallop, elevated jugular venous pressure, cardiomegaly, and a markedly elevated brain natriuretic peptide (BNP) level. This clinical picture is diagnostic of acute decompensated heart failure (ADHF) resulting in pulmonary edema. Although the patient has a history of COPD and presents with wheezing, this represents 'cardiac asthma', a phenomenon where peribronchial edema leads to airway narrowing and wheezing. The presence of an S3 gallop is highly specific for heart failure in this context. The initial pharmacologic management for ADHF with volume overload consists of intravenous loop diuretics, such as furosemide, which promptly reduce preload and pulmonary venous pressure, thereby relieving dyspnea.

Step-by-Step Solution

1
Analyze the patient's symptoms and vital signs.
The patient has progressive dyspnea, orthopnea, hypoxemia, and hypertension, which suggests an acute cardiopulmonary process.
Identifying the primary symptom cluster directs the differential diagnosis.
2
Interpret the physical examination and imaging findings.
Findings include an S3 gallop, elevated jugular venous pressure, cardiomegaly, and bilateral pleural effusions. Although wheezing is present, these signs strongly indicate fluid overload and heart failure rather than an isolated COPD exacerbation.
Physical exam and imaging distinguish between cardiac asthma (wheezing due to pulmonary edema) and primary airway disease.
3
Evaluate the laboratory results.
The BNP is significantly elevated (920 pg/mL920\text{ pg/mL}), confirming the diagnosis of heart failure. The mild TSH elevation is subclinical. The ABG shows acute respiratory acidosis without a metabolic component.
Biomarkers like BNP help confirm the clinical suspicion of heart failure in complex presentations where comorbid lung disease exists.
4
Determine the most appropriate pharmacologic intervention.
Given the diagnosis of acute decompensated heart failure with volume overload, preload reduction is required. Intravenous furosemide is the standard initial therapy.
Loop diuretics rapidly reduce pulmonary congestion and improve respiratory status in ADHF.

Key Concept

Patients with acute decompensated heart failure can present with wheezing ('cardiac asthma') mimicking a COPD exacerbation. An S3 gallop, elevated JVP, cardiomegaly, and markedly elevated BNP differentiate ADHF, which requires prompt management with intravenous loop diuretics.
Question 2944Question →

A 28-year-old woman comes to the clinic for evaluation of an elevated calcium level discovered during a routine life insurance medical examination. The patient is completely asymptomatic and reports no fatigue, weakness, abdominal pain, constipation, or bone pain. She exercises regularly and takes no medications or over-the-counter supplements. Her family history is notable for her mother having "mildly elevated calcium" that persisted despite undergoing a parathyroidectomy several years ago. Vital signs and physical examination are unremarkable.

Laboratory studies show:
Serum calcium: 11.3 mg/dL11.3\text{ mg/dL}
Albumin: 4.0 g/dL4.0\text{ g/dL}
Serum phosphorus: 2.6 mg/dL2.6\text{ mg/dL}
Creatinine: 0.8 mg/dL0.8\text{ mg/dL}
Intact parathyroid hormone: 62 pg/mL62\text{ pg/mL} (normal: 10−65 pg/mL10-65\text{ pg/mL})

Which of the following is the most appropriate next step in the evaluation of this patient?

Show answer & explanation

Answer: Measurement of urine calcium-to-creatinine clearance ratio

Answer

Measurement of the urine calcium-to-creatinine clearance ratio is the next best step to differentiate familial hypocalciuric hypercalcemia from primary hyperparathyroidism.
The correct answer is measurement of the urine calcium-to-creatinine clearance ratio (UCCR). This patient has mild, asymptomatic hypercalcemia with an inappropriately normal intact parathyroid hormone (PTH) level. In a normal physiologic state, hypercalcemia completely suppresses PTH secretion. Therefore, a PTH level in the upper half of the normal reference range (62 pg/mL62\text{ pg/mL}) in the setting of hypercalcemia indicates PTH-dependent hypercalcemia. The primary differential diagnosis for PTH-dependent hypercalcemia includes primary hyperparathyroidism and familial hypocalciuric hypercalcemia (FHH). This patient's family history of persistent hypercalcemia despite a parathyroidectomy strongly suggests FHH. FHH is an autosomal dominant disorder caused by an inactivating mutation in the calcium-sensing receptor (CaSR) located in the parathyroid glands and kidneys. This mutation leads to higher calcium levels being required to suppress PTH, as well as increased renal calcium reabsorption. The next best step to differentiate FHH from primary hyperparathyroidism is a urine collection to calculate the UCCR. A UCCR of less than 0.01 is highly suggestive of FHH, whereas a value greater than 0.02 points toward primary hyperparathyroidism. Recognizing FHH is crucial because it is a benign condition that does not require surgical intervention.

Step-by-Step Solution

1
Evaluate the relationship between the serum calcium and intact parathyroid hormone (PTH) levels.
The patient has hypercalcemia (11.3 mg/dL11.3\text{ mg/dL}) with a concurrently high-normal PTH (62 pg/mL62\text{ pg/mL}).
In the presence of hypercalcemia, a normal parathyroid gland should be strongly suppressed (PTH <20 pg/mL< 20\text{ pg/mL}). A value of 62 pg/mL62\text{ pg/mL} is inappropriately unsuppressed, indicating PTH-dependent hypercalcemia.
2
Formulate a differential diagnosis for PTH-dependent hypercalcemia based on the patient's history.
The primary differential includes primary hyperparathyroidism and familial hypocalciuric hypercalcemia (FHH).
The patient's family history of persistent hypercalcemia despite a parathyroidectomy strongly suggests FHH rather than primary hyperparathyroidism.
3
Identify the diagnostic test required to differentiate FHH from primary hyperparathyroidism.
Measurement of the 24-hour urine calcium-to-creatinine clearance ratio (UCCR).
FHH is characterized by increased renal calcium reabsorption resulting in a UCCR <0.01< 0.01, whereas primary hyperparathyroidism typically presents with a UCCR >0.02> 0.02.

Key Concept

The evaluation of PTH-dependent hypercalcemia and differentiating familial hypocalciuric hypercalcemia (FHH) from primary hyperparathyroidism.
Estimated Time:1m 30s
Question 2945Question →

A 58-year-old man is evaluated in the emergency department for sudden-onset, severe, "tearing" chest pain that radiates to his back. The pain began one hour ago while he was lifting heavy boxes. He has a history of poorly controlled hypertension. His temperature is 37.2°C (99.0°F), pulse is 112/min, and respirations are 22/min. Blood pressure is 215/115 mm Hg in the right arm and 175/95 mm Hg in the left arm. Physical examination reveals a new early diastolic decrescendo murmur heard best at the right upper sternal border. An electrocardiogram shows sinus tachycardia and left ventricular hypertrophy without acute ischemic changes. Chest radiography reveals a widened mediastinum.

Arrange the following patient management steps in the most appropriate chronological order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to initiate anti-impulse therapy with an intravenous beta-blocker, followed by an intravenous vasodilator, then confirm the diagnosis with a computed tomography angiogram, and finally proceed to emergent surgical repair.
The correct chronological management of acute aortic dissection prioritizes immediate reduction of aortic wall shear stress (anti-impulse therapy). This begins with an intravenous beta-blocker (e.g., esmolol) to reduce heart rate and left ventricular contractility (dP/dt). Once the heart rate is controlled, an intravenous vasodilator (e.g., sodium nitroprusside) is added to achieve a target systolic blood pressure of 100-120 mm Hg. After medical stabilization is initiated, the patient should undergo a computed tomography angiogram to confirm the diagnosis and define the anatomy. Because this patient has signs of ascending aortic involvement (right arm hypertension, aortic regurgitation murmur), it is a Stanford Type A dissection, which ultimately requires emergent surgical repair.

Step-by-Step Solution

1
Administer an intravenous beta-adrenergic antagonist (e.g., esmolol).
Heart rate and left ventricular contractility are decreased.
Reduces aortic wall shear stress (dP/dt). This must be done first to prevent dissection propagation.
2
Administer an intravenous vasodilator (e.g., sodium nitroprusside).
Systolic blood pressure is rapidly lowered to a target of 100-120 mm Hg.
Further decreases wall stress. It is given second because administering it without prior beta-blockade causes reflex tachycardia and increased contractility, which can worsen the dissection.
3
Obtain a computed tomography angiogram of the chest and abdomen.
Confirmation of the dissection flap and anatomic classification (Stanford Type A).
Definitive imaging is necessary to plan the surgical approach, but only after initial hemodynamic control has been established to prevent imminent rupture.
4
Proceed with emergent operative repair of the ascending aorta.
Surgical replacement of the ascending aorta and potential aortic valve repair.
Stanford Type A dissections carry a significantly high mortality rate if treated medically alone. Emergent surgery is the definitive treatment.

Key Concept

In the management of acute aortic dissection, initial stabilization requires strict anti-impulse therapy starting with a beta-blocker, followed by a vasodilator, before obtaining definitive imaging and proceeding to surgical repair.
Question 2946Question →

A 5858-year-old man is brought to the emergency department complaining of sudden-onset, severe, "tearing" chest pain that radiates to his back. He appears diaphoretic and is in acute distress. Vital signs show a blood pressure of 210/115210/115 mmHg in the right arm and 175/95175/95 mmHg in the left arm, a heart rate of 112112/min, and a respiratory rate of 2020/min. An electrocardiogram shows sinus tachycardia with no ST-segment or T-wave abnormalities. A portable chest x-ray reveals a widened mediastinum. Arrange the following steps in the most appropriate chronological order for the acute management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first initiate intravenous esmolol, followed by intravenous nitroprusside, then obtain a CT angiography of the aorta, and finally consult cardiothoracic surgery.
The correct sequence strictly prioritizes hemodynamic stabilization using anti-impulse therapy before obtaining definitive imaging and surgical consultation. Intravenous beta-blockers (e.g., esmolol) must be administered first to decrease the heart rate and reduce the force of left ventricular ejection. Only after adequate beta-blockade is established should a vasodilator (e.g., nitroprusside) be initiated to further lower the blood pressure safely. Proceeding to CT angiography and subsequent surgical consultation should only occur after the patient's hemodynamics are strictly controlled to minimize the risk of acute aortic rupture during transport and evaluation.

Step-by-Step Solution

1
Assess hemodynamics and establish clinical goals.
Identify a hypertensive emergency in the setting of a highly suspected acute aortic dissection.
Targeting a heart rate less than 6060/min and a systolic blood pressure of 100100 to 120120 mmHg is required immediately to prevent dissection propagation.
2
Administer a negative inotrope and chronotrope.
Intravenous esmolol (or labetalol) is given as the first pharmacological intervention.
Beta-blockade decreases dP/dt and prevents the reflex tachycardia that would otherwise occur from subsequent vasodilator use.
3
Administer a vasodilator.
Intravenous nitroprusside is added.
Provides necessary afterload reduction to meet strict systolic blood pressure goals, safely administered only after the heart rate is controlled.
4
Confirm the diagnosis with definitive imaging.
CT angiography of the aorta is performed.
Visualizes the intimal flap and classifies the dissection anatomically (Stanford type A or B), which dictates definitive management.
5
Determine definitive treatment based on anatomy.
Cardiothoracic surgery is consulted.
Type A dissections (and complicated Type B dissections) require emergent surgical or endovascular intervention.

Key Concept

In the acute management of aortic dissection, anti-impulse therapy must be initiated with a beta-blocker before any vasodilators are given, and hemodynamic stabilization must precede transport for advanced imaging.
Estimated Time:1m 30s
Question 2947Question →

During a routine occupational health evaluation, a 49-year-old construction worker is found to have a blood pressure of 192/115 mm Hg192/115\text{ mm Hg}. When questioned, he reports experiencing unprovoked spells of intense diaphoresis, forceful heart palpitations, and throbbing headaches over the past three months. His physician strongly suspects a catecholamine-secreting adrenal medullary tumor.

Arrange the following diagnostic and therapeutic interventions in the correct sequential order for managing this patient's suspected condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Biochemical testing, followed by Anatomical imaging, then Alpha-blockade, followed by Beta-blockade, and finally Surgical resection.
The algorithmic approach to suspected pheochromocytoma requires confirming the biochemical diagnosis first to avoid the pitfall of pursuing non-functioning adrenal incidentalomas. Once confirmed biochemically, cross-sectional imaging is used to localize the mass. Preoperative medical preparation is essential to prevent intraoperative hypertensive crises. Alpha-adrenergic blockade MUST be initiated first to induce vasodilation and allow volume expansion. Only after adequate alpha-blockade has been established should beta-adrenergic blockade be introduced to manage tachycardia. Definitive surgical resection is the final step once the patient is hemodynamically optimized.

Step-by-Step Solution

1
Confirm the diagnosis biochemically.
Elevated plasma free metanephrines or 24-hour urine metanephrines.
Biochemical testing prevents false-positive diagnoses caused by non-functioning adrenal incidentalomas, which are common findings on imaging.
2
Localize the tumor.
Identification of an adrenal or extra-adrenal mass on CT or MRI.
Imaging is required to identify the specific anatomical location of the tumor to properly plan the surgical approach.
3
Initiate preoperative medical optimization with alpha-blockade.
Administration of phenoxybenzamine or doxazosin.
Alpha-blockade causes vasodilation, which controls blood pressure and restores the chronically contracted plasma volume.
4
Add beta-blockade to the medical regimen.
Administration of propranolol or metoprolol.
Beta-blockers control catecholamine-induced tachyarrhythmias, but they must NEVER be given before alpha-blockers to avoid precipitating a hypertensive crisis.
5
Perform definitive surgical treatment.
Adrenalectomy or tumor resection.
Surgical removal cures the condition and is safe to perform only after adequate preoperative receptor blockade is achieved.

Key Concept

Diagnosis and management algorithm for pheochromocytoma, specifically the necessity of biochemical testing prior to imaging and alpha-blockade prior to beta-blockade.
Question 2948Question →

A 6464-year-old woman is brought to the triage desk by her family due to extreme lightheadedness and a progressive inability to catch her breath over the past three days. She has a medical history significant for severe rheumatoid arthritis and chronic obstructive pulmonary disease. Two weeks ago, she experienced a self-limiting febrile viral illness. On examination, the patient appears visibly distressed and diaphoretic. Vital signs show a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), heart rate of 118/min118\text{/min}, respiratory rate of 24/min24\text{/min}, and blood pressure of 86/60 mmHg86/60\text{ mmHg}. During normal inspiration, her systolic blood pressure decreases by 18 mmHg18\text{ mmHg}. Jugular venous distention is prominent up to the angle of the mandible while she sits upright. Pulmonary auscultation reveals globally distant breath sounds but no crackles or active wheezing. Cardiac auscultation is limited by an increased anterior-posterior chest diameter, and no murmurs are appreciated. An electrocardiogram demonstrates a regular tachycardia with low-voltage QRS complexes in the limb leads and shifting electrical axes. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Performance of urgent bedside echocardiography

Answer

Performance of urgent bedside echocardiography
The correct answer is performance of urgent bedside echocardiography. This patient is presenting with classic signs of cardiac tamponade: hypotension, elevated jugular venous pressure, and distant heart sounds (Beck's triad). Her recent viral illness likely triggered acute pericarditis, culminating in a malignant pericardial effusion. The diagnosis is further supported by the presence of pulsus paradoxus (an exaggerated >10 mmHg>10\text{ mmHg} drop in systolic pressure during inspiration due to the bowing of the interventricular septum into the left ventricle) and electrical alternans on the electrocardiogram (caused by the heart swinging back and forth within the fluid-filled pericardial sac). In a hemodynamically unstable patient, the immediate next step is point-of-care bedside echocardiography to confirm the effusion and visualize right heart collapse before proceeding to life-saving pericardiocentesis.

Step-by-Step Solution

1
Analyze the patient's hemodynamic profile and vital signs.
The patient is hypotensive (86/60 mmHg86/60\text{ mmHg}) and tachycardic, with a significant pulsus paradoxus (18 mmHg18\text{ mmHg} drop in systolic blood pressure during inspiration).
Identifying the pattern of shock is critical for triaging interventions.
2
Interpret the physical examination and diagnostic findings in the context of her history.
The combination of jugular venous distention, clear lungs, and low-voltage electrocardiogram with electrical alternans (shifting axes) strongly points away from her underlying chronic obstructive pulmonary disease and toward a pericardial process.
The recent viral illness likely caused acute viral pericarditis, which has now evolved into a large pericardial effusion.
3
Determine the optimal diagnostic or therapeutic intervention for suspected cardiac tamponade.
Urgent bedside echocardiography must be performed.
Echocardiography rapidly and noninvasively confirms the diagnosis of cardiac tamponade (showing right atrial and ventricular diastolic collapse) and helps guide immediate pericardiocentesis.

Key Concept

Diagnosis and initial management of cardiac tamponade
Question 2949Question →

An emergency department physician is evaluating a 63-year-old man who presents with four days of progressively worsening shortness of breath. The patient reports a noticeable increase in both the volume and purulence of his daily sputum. His medical history is significant for severe tobacco use disorder, chronic obstructive pulmonary disease, and mild ischemic cardiomyopathy. His current home medications include inhaled tiotropium, inhaled fluticasone-vilanterol, and low-dose carvedilol.

Upon arrival, his temperature is 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), blood pressure is 148/92 mmHg148/92\text{ mmHg}, pulse is 108/min108\text{/min}, and respiratory rate is 26/min26\text{/min}. Oxygen saturation is 85%85\% on ambient air.

Physical examination reveals a patient in moderate respiratory distress, sitting in a tripod position with prominent accessory muscle use. Auscultation of the lungs demonstrates a significantly prolonged expiratory phase with diffuse, bilateral expiratory wheezing. Jugular venous pressure is estimated at 6 cm H2O6\text{ cm H}_2\text{O}, and there is no peripheral edema.

Arterial blood gas analysis obtained on room air shows:
pH\text{pH}: 7.267.26
PaCO2\text{PaCO}_2: 66 mmHg66\text{ mmHg}
PaO2\text{PaO}_2: 54 mmHg54\text{ mmHg}
HCO3−\text{HCO}_3^-: 29 mEq/L29\text{ mEq/L}

A portable chest radiograph displays hyperinflated lung fields with flattened diaphragms, without focal consolidations, pleural effusions, or cardiomegaly.

Which of the following interventions are appropriate for the acute management of this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Initiation of noninvasive bilevel positive airway pressure ventilation; Administration of a short course of systemic glucocorticoids

Answer

The appropriate interventions for this patient are the initiation of noninvasive bilevel positive airway pressure ventilation and the administration of a short course of systemic glucocorticoids.
This patient is experiencing a severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD) complicated by acute-on-chronic hypercapnic respiratory failure. In patients with an AECOPD who demonstrate respiratory distress and respiratory acidemia (defined as a pH < 7.30 and PaCO2 > 45 mmHg), noninvasive positive pressure ventilation (NIPPV, such as BiPAP) is the initial airway management of choice. NIPPV has been shown to decrease mortality, reduce the need for endotracheal intubation, and shorten hospital stays. Furthermore, the administration of systemic glucocorticoids (e.g., oral prednisone or intravenous methylprednisolone) is indicated for all patients requiring hospital evaluation for a COPD exacerbation. Glucocorticoids reduce airway inflammation, improve lung function (FEV1), and significantly shorten the recovery time.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient has a history of COPD and presents with increased dyspnea, increased sputum volume, and increased sputum purulence, indicating an acute COPD exacerbation.
Identifying the primary clinical syndrome is necessary to guide targeted therapy and rule out competing diagnoses like heart failure.
2
Evaluate the objective data, specifically the arterial blood gas (ABG) and chest radiograph.
The ABG shows acidemia (pH 7.26) driven by hypercapnia (PaCO2 66 mmHg), with an elevated bicarbonate (29 mEq/L) indicating an acute-on-chronic respiratory acidosis. The chest X-ray shows hyperinflation without signs of heart failure or pneumonia.
ABG results dictate the need for and type of mechanical ventilatory support.
3
Determine the indications for respiratory and medical interventions.
The presence of respiratory acidemia (pH < 7.30) mandates noninvasive positive pressure ventilation (NIPPV). The severe exacerbation also mandates systemic glucocorticoids and narrow-spectrum antibiotics (such as a macrolide).
Applying standard-of-care guidelines for acute COPD exacerbations reduces mortality and intubation rates.

Key Concept

Management of severe acute COPD exacerbation complicated by hypercapnic respiratory failure requires noninvasive positive pressure ventilation (NIPPV), systemic glucocorticoids, inhaled bronchodilators, and targeted antibiotics.
Question 2950Question →

A 58-year-old man with a history of alcohol-associated cirrhosis and refractory ascites is hospitalized due to an acute rise in serum creatinine. Over the past week, his weight has increased by 44 kg (8.88.8 lbs), and his urine output has decreased. His home medications include furosemide, spironolactone, and nadolol. On admission, his temperature is 37.1∘37.1^\circ C (98.8∘98.8^\circ F), blood pressure is 90/6090/60 mm Hg, and pulse is 9898/min. Physical examination reveals scleral icterus, spider angiomas, and a markedly distended abdomen with shifting dullness. There is no abdominal tenderness, rebound, or guarding. Lungs are clear to auscultation. Laboratory studies on admission reveal:

Sodium: 131131 mEq/L
Potassium: 4.24.2 mEq/L
Bicarbonate: 2222 mEq/L
BUN: 4545 mg/dL
Creatinine: 2.82.8 mg/dL (baseline 1.11.1 mg/dL one month ago)
Total bilirubin: 3.53.5 mg/dL

Diagnostic paracentesis yields clear, yellow fluid with a leukocyte count of 120120/mm 3^3 (10%10\% neutrophils) and negative Gram stain. All diuretics and nadolol are discontinued. He is given intravenous albumin at a dose of 11 g/kg/day. Forty-eight hours later, his blood pressure is 92/6092/60 mm Hg and pulse is 9595/min. Repeat laboratory studies show a serum creatinine of 3.13.1 mg/dL. Urinalysis reveals no red blood cells, white blood cells, or casts. Urine sodium concentration is 88 mEq/L. Renal ultrasound shows normal kidney size with no hydronephrosis. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate combination therapy with midodrine and octreotide

Answer

The most appropriate next step is to initiate combination therapy with midodrine and octreotide, along with continued intravenous albumin.
This patient meets all the classic diagnostic criteria for hepatorenal syndrome (HRS), specifically HRS-AKI (formerly Type 1 HRS). HRS is a functional renal failure seen in advanced cirrhosis. It is caused by severe splanchnic arterial vasodilation, which critically reduces the effective arterial blood volume. This triggers intense activation of the renin-angiotensin-aldosterone system and the sympathetic nervous system, resulting in profound reflex renal vasoconstriction. The diagnosis requires the presence of cirrhosis with ascites, acute kidney injury, the absence of other causes of AKI (such as shock or nephrotoxic drugs), the lack of intrinsic renal disease (evidenced by a bland urinalysis and normal ultrasound), and the failure of renal function to improve after at least 48 hours of diuretic withdrawal and volume expansion with intravenous albumin. Because the core pathophysiology is splanchnic vasodilation, the treatment of choice relies on splanchnic vasoconstrictors. In the United States, a combination of midodrine (an alpha-1 adrenergic agonist) and octreotide (a somatostatin analog), along with continued albumin infusions, is the standard medical therapy. Terlipressin and norepinephrine are also utilized as first-line therapies depending on availability and care setting.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and initial laboratory findings.
The patient has advanced cirrhosis with refractory ascites and a new-onset acute kidney injury (serum creatinine increased from 1.11.1 to 2.82.8 mg/dL).
Establishing the presence of severe AKI in the setting of portal hypertension is the first step in the diagnostic algorithm for renal failure in cirrhosis.
2
Evaluate the response to diuretic withdrawal and targeted volume expansion.
Despite stopping all diuretics and administering intravenous albumin (11 g/kg/day) for 4848 hours, the serum creatinine worsened to 3.13.1 mg/dL.
This lack of response strictly rules out simple volume depletion (pre-renal azotemia) and fulfills a core diagnostic criterion for hepatorenal syndrome.
3
Rule out other intrinsic and post-renal causes of acute kidney injury.
The urinalysis is completely bland, urine sodium is profoundly low (88 mEq/L), ultrasound shows no obstruction, and there is no shock or nephrotoxic drug use.
This definitively rules out intrinsic renal parenchymal disease (such as acute tubular necrosis) and post-renal obstruction.
4
Determine the appropriate treatment for the established diagnosis.
The diagnosis is hepatorenal syndrome (HRS-AKI). The definitive medical treatment requires splanchnic vasoconstrictors (midodrine and octreotide, or terlipressin) in addition to albumin.
HRS is driven by profound splanchnic vasodilation; using specific vasoconstrictors reverses this pathophysiology, increases effective arterial blood volume, and restores renal perfusion.

Key Concept

Diagnosis and management of Hepatorenal Syndrome (HRS-AKI)
Question 2951Question →

Match the following structural heart diseases with their characteristic dynamic auscultation findings elicited during physical maneuvers.

Click a left item, then click its matching right item

Items

Hypertrophic obstructive cardiomyopathy
Mitral valve prolapse
Valvular aortic stenosis
Mitral regurgitation

Matches

Show answer & explanation

Answer

Hypertrophic obstructive cardiomyopathy corresponds to the murmur that becomes louder with Valsalva strain; Mitral valve prolapse corresponds to the click moving closer to S1S_1 upon sudden standing; Valvular aortic stenosis corresponds to the murmur that becomes softer with isometric handgrip; Mitral regurgitation corresponds to the murmur that becomes louder with isometric handgrip.
Dynamic maneuvers are essential for distinguishing cardiac murmurs by predictably altering hemodynamics. Decreased preload (from the Valsalva maneuver or standing) reduces left ventricular volume, which intensifies the hypertrophic obstructive cardiomyopathy murmur by worsening the outflow obstruction, and causes an earlier click in mitral valve prolapse. Conversely, increased afterload (from isometric handgrip) elevates aortic pressure, which softens the aortic stenosis murmur by decreasing the forward pressure gradient, but intensifies the mitral regurgitation murmur by driving more backward flow.

Step-by-Step Solution

1
Analyze the maneuvers that decrease left ventricular preload (Valsalva strain, sudden standing).
These maneuvers decrease venous return, resulting in a smaller left ventricular chamber size.
To understand their specific effects on volume-dependent dynamic murmurs such as hypertrophic obstructive cardiomyopathy and mitral valve prolapse.
2
Match the preload-dependent pathologies to their corresponding clinical findings.
In hypertrophic obstructive cardiomyopathy, reduced chamber volume worsens the dynamic obstruction, increasing the murmur. In mitral valve prolapse, reduced volume causes the redundant leaflets to prolapse earlier, moving the click closer to S1S_1.
Correctly pairs the first two structural diseases with their physiological responses.
3
Analyze the maneuvers that increase left ventricular afterload (isometric handgrip).
Isometric handgrip primarily increases systemic vascular resistance and aortic pressure.
To determine its divergent effects on fixed stenotic versus regurgitant valvular lesions.
4
Match the afterload-dependent pathologies to their corresponding clinical findings.
In aortic stenosis, increased aortic pressure reduces the forward transvalvular gradient, softening the murmur. In mitral regurgitation, increased systemic resistance forces more blood backward into the left atrium, increasing the murmur intensity.
Correctly pairs the remaining two structural diseases with their physiological responses.

Key Concept

The physiological effects of dynamic auscultation maneuvers (preload and afterload alterations) on the intensity and timing of cardiac murmurs.
Estimated Time:1m 30s
Question 2952Question →

A 21-year-old man with a history of type 1 diabetes mellitus is brought to the emergency department due to altered mental status, nausea, and abdominal pain for the past 24 hours. He recently had a respiratory tract infection and missed several doses of insulin due to poor appetite. On physical examination, his temperature is 37.4°C (99.3°F), blood pressure is 90/60 mm Hg, pulse is 118/min, and respiratory rate is 28/min with deep, rapid breathing. His mucous membranes are extremely dry. Laboratory studies reveal:

Serum glucose: 580 mg/dL580\text{ mg/dL}
Serum sodium: 132 mEq/L132\text{ mEq/L}
Serum potassium: 4.9 mEq/L4.9\text{ mEq/L}
Serum bicarbonate: 11 mEq/L11\text{ mEq/L}
Arterial blood gas: pH 7.187.18
Serum ketones: Positive

Arrange the following management steps in the most appropriate chronological sequence for the acute and subacute treatment of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Administer a rapid intravenous bolus of 0.9% normal saline, followed by initiating a continuous intravenous regular insulin infusion, then adding 5% dextrose to the maintenance intravenous fluids, followed by administering a dose of subcutaneous long-acting basal insulin, and finally discontinuing the continuous intravenous regular insulin infusion.
The correct sequence strictly follows the established algorithm for treating diabetic ketoacidosis (DKA). Initial management focuses on aggressive fluid resuscitation with isotonic saline to stabilize hemodynamics and improve tissue perfusion. Once fluids are running and potassium is verified to be ≥3.3 mEq/L\ge 3.3\text{ mEq/L} (the patient's is 4.9 mEq/L4.9\text{ mEq/L}), an intravenous regular insulin infusion is started to suppress lipolysis and correct acidosis. As the insulin works, serum glucose falls faster than ketones clear. To prevent hypoglycemia while waiting for the anion gap to close, 5%5\% dextrose is added to the fluids when glucose reaches 200−250 mg/dL200-250\text{ mg/dL}. Finally, once the gap closes and the patient is stable to eat, a subcutaneous basal insulin dose is given. The intravenous insulin drip is discontinued 1-2 hours later to provide necessary overlap and prevent rebound DKA.

Step-by-Step Solution

1
Restore intravascular volume.
Administer 0.9% normal saline bolus.
The patient is hypotensive and severely dehydrated due to osmotic diuresis. Volume resuscitation is the absolute first step in management.
2
Correct hyperglycemia and ketonemia.
Initiate continuous intravenous regular insulin.
Insulin inhibits lipolysis and ketone production. It is safe to start immediately after fluids because the initial serum potassium is adequate (4.9 mEq/L).
3
Prevent hypoglycemia during treatment.
Add 5% dextrose to maintenance intravenous fluids.
Glucose levels typically normalize before ketoacidosis resolves. Dextrose is required to allow the continuation of the insulin infusion until the anion gap completely closes.
4
Transition to maintenance therapy.
Administer subcutaneous long-acting basal insulin.
Once the ketoacidosis resolves (anion gap closes, pH > 7.3) and the patient can eat, long-acting insulin must be administered before stopping the acute treatment.
5
Cease acute intravenous therapy.
Discontinue the continuous intravenous regular insulin infusion.
The intravenous insulin infusion should be discontinued 1 to 2 hours after the subcutaneous insulin is given. This overlap prevents an insulin-deficient window that could lead to rebound diabetic ketoacidosis.

Key Concept

Management Sequence of Diabetic Ketoacidosis (DKA)
Estimated Time:1m 30s
Question 2953Question →

A 19-year-old woman is brought to the emergency department by her roommate due to nausea, vomiting, and "ringing" in her ears. The roommate reports that the patient was distraught after a severe argument and ingested an unknown quantity of an over-the-counter pain medication approximately 5 hours ago. On physical examination, her temperature is 37.8°C (100.0°F), blood pressure is 112/68 mm Hg, pulse is 115/min, and respirations are 32/min. She appears agitated and is breathing deeply and rapidly. Her lungs are clear to auscultation bilaterally.

Laboratory studies show:
* Serum sodium: 139139 mEq/L
* Serum potassium: 3.73.7 mEq/L
* Serum chloride: 103103 mEq/L
* Serum bicarbonate: 1414 mEq/L
* Blood urea nitrogen: 1616 mg/dL
* Serum creatinine: 0.90.9 mg/dL

Arterial blood gas analysis on room air reveals:
* pH: 7.467.46
* PaCO2PaCO_2: 2020 mm Hg
* PaO2PaO_2: 105105 mm Hg
* HCO3−HCO_3^-: 1414 mEq/L

Based on the laboratory findings, which of the following best describes this patient's current acid-base disturbance?

Show answer & explanation

Answer: Concurrent primary high anion-gap metabolic acidosis and primary respiratory alkalosis

Answer

Concurrent primary high anion-gap metabolic acidosis and primary respiratory alkalosis
This patient presents with classic features of salicylate toxicity (aspirin overdose), including tinnitus, nausea, tachypnea, and agitation. Salicylates directly stimulate the medullary respiratory center, leading to hyperventilation and a primary respiratory alkalosis. Shortly after, the accumulation of organic acids causes a primary high anion-gap metabolic acidosis.

To diagnose this mixed disorder systematically:
1. Calculate the anion gap (AG): AG=Na+−(Cl−+HCO3−)=139−(103+14)=22AG = Na^+ - (Cl^- + HCO_3^-) = 139 - (103 + 14) = 22 mEq/L. An AG >12> 12 mEq/L confirms a primary high anion-gap metabolic acidosis.
2. Determine the expected respiratory compensation using Winter's formula: Expected PaCO2=(1.5×HCO3−)+8±2=(1.5×14)+8±2=29±2PaCO_2 = (1.5 \times HCO_3^-) + 8 \pm 2 = (1.5 \times 14) + 8 \pm 2 = 29 \pm 2 mm Hg.
3. Compare actual vs expected PaCO2PaCO_2: The actual PaCO2PaCO_2 is 2020 mm Hg, which is significantly lower than the expected range. This means the patient is blowing off more CO2CO_2 than can be explained by simple compensation, confirming an independent, concurrent primary respiratory alkalosis. Furthermore, simple compensation will never result in an overcorrection to an alkalemic pH (7.467.46).

Step-by-Step Solution

1
Calculate the serum anion gap to evaluate for metabolic acidosis.
Anion Gap = 139−(103+14)=22139 - (103 + 14) = 22 mEq/L.
An anion gap greater than 1212 mEq/L confirms the presence of a primary high anion-gap metabolic acidosis (HAGMA), regardless of the overall pH.
2
Assess the arterial pH to identify the dominating acid-base disorder.
The pH is 7.467.46 (alkalemia).
A pH >7.45> 7.45 indicates that the net or dominating disturbance is an alkalosis. Since the patient has a confirmed metabolic acidosis (from the high AG), there MUST be a concurrent, stronger alkalosis driving the pH up.
3
Apply Winter's formula to determine the expected PaCO2PaCO_2 and identify the specific respiratory disturbance.
Expected PaCO2=(1.5×14)+8=29±2PaCO_2 = (1.5 \times 14) + 8 = 29 \pm 2 mm Hg. The actual PaCO2PaCO_2 (2020 mm Hg) is much lower than the expected range (27−3127-31 mm Hg).
Because the actual PaCO2PaCO_2 is significantly lower than the predicted compensatory range, there is a distinct, concurrent primary respiratory alkalosis rather than just appropriate compensation for the metabolic acidosis.

Key Concept

Salicylate toxicity classically causes a mixed acid-base disturbance: an early primary respiratory alkalosis (due to direct medullary respiratory center stimulation) and a concurrent primary high anion-gap metabolic acidosis (due to the accumulation of unmeasured organic acids like lactate, ketones, and salicylates).
Estimated Time:1m 0s
Question 2954Question →

Two weeks after completing a course of oral moxifloxacin for a community-acquired lower respiratory tract infection, a 7171-year-old male presents to the urgent care clinic complaining of profuse, watery diarrhea. He reports having up to 88 loose bowel movements daily, accompanied by diffuse abdominal cramps and subjective fever. His temperature is 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), pulse is 102/min102/\text{min}, and blood pressure is 114/72 mmHg114/72\text{ mmHg}. Physical examination reveals a mildly distended abdomen with generalized tenderness to palpation, but no guarding or rigidity. Laboratory evaluation shows a leukocyte count of 18,500/mm318,500/\text{mm}^3 and a serum creatinine level of 1.4 mg/dL1.4\text{ mg/dL} (baseline 1.0 mg/dL1.0\text{ mg/dL}). Enzyme immunoassay of the stool is positive for glutamate dehydrogenase antigen and *Clostridioides difficile* toxins A and B. Which of the following is the most appropriate pharmacotherapy for this patient's current condition?

Show answer & explanation

Answer: Oral fidaxomicin

Answer

The correct intervention is the administration of oral fidaxomicin.
This patient is presenting with an initial episode of severe *Clostridioides difficile* infection (CDI), supported by typical symptoms, recent antibiotic exposure, marked leukocytosis (>15,000/mm3> 15,000/\text{mm}^3), and positive stool assays. Current clinical guidelines strongly recommend the use of oral fidaxomicin or oral vancomycin as the first-line pharmacotherapy for both non-severe and severe initial episodes of CDI. Fidaxomicin is a bactericidal macrocyclic antibiotic with a narrow spectrum of activity specifically targeting *C. difficile*. Its minimal systemic absorption and highly targeted nature help preserve normal enteric flora, significantly reducing the risk of disease recurrence compared to older therapies.

Step-by-Step Solution

1
Diagnose the patient's condition based on the clinical presentation and laboratory results.
The positive stool assay and recent antibiotic use confirm an initial episode of Clostridioides difficile infection (CDI).
Establishing the specific infectious etiology is necessary to guide targeted antimicrobial therapy.
2
Stratify the severity of the infection.
The leukocyte count of 18,500/mm318,500/\text{mm}^3 (greater than 15,000/mm315,000/\text{mm}^3) classifies this as a severe episode.
Historically, severity guided therapy, although current guidelines recommend the same first-line agents for both non-severe and severe initial episodes.
3
Select the guideline-concordant antimicrobial therapy.
Oral fidaxomicin (or oral vancomycin) is chosen.
Current Infectious Diseases Society of America (IDSA) guidelines recommend narrow-spectrum agents like fidaxomicin over older therapies to maximize cure rates and minimize recurrences.

Key Concept

Management of initial Clostridioides difficile infection
Estimated Time:1m 30s
Question 2955Question →

A 31-year-old male is admitted to the general medical ward for evaluation of severe right arm pain and persistent fevers. He reports a history of injection drug use. His vital signs on admission include a temperature of 39.1°C (102.4°F), blood pressure of 112/70 mm Hg, and a heart rate of 115/min. Physical examination of the right upper extremity reveals a 4-cm area of fluctuance with overlying warmth and marked erythema. Initial blood cultures are obtained, and he is empirically commenced on intravenous vancomycin and piperacillin-tazobactam. An echocardiogram shows structurally normal valves with no vegetations. Over the subsequent two days, the patient defervesces and the localized arm erythema improves. The laboratory reports that the admission blood cultures are positive in all bottles for Staphylococcus aureus. Antimicrobial susceptibility testing demonstrates resistance to penicillin but susceptibility to oxacillin, cefazolin, daptomycin, and vancomycin. Which of the following is the most appropriate modification to his antimicrobial therapy?

Show answer & explanation

Answer: Replace the current regimen with intravenous cefazolin

Answer

Replace the current regimen with intravenous cefazolin
The patient has methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. For MSSA infections, targeted therapy with a narrow-spectrum, anti-staphylococcal beta-lactam (such as cefazolin, nafcillin, or oxacillin) is the definitive standard of care. These agents are significantly superior to vancomycin for MSSA, demonstrating faster bacterial clearance rates, lower associated mortality, and reduced toxicity. Therefore, the most appropriate next step is to discontinue the broad-spectrum empiric regimen and initiate intravenous cefazolin.

Step-by-Step Solution

1
Identify the specific pathogen and its susceptibility profile from the laboratory results.
The pathogen is identified as methicillin-susceptible Staphylococcus aureus (MSSA), as it is susceptible to oxacillin and cefazolin.
Determining the specific organism and its resistance pattern is required to transition from empiric to targeted therapy.
2
Evaluate the patient's current empiric antimicrobial regimen.
The patient is receiving broad-spectrum coverage with vancomycin (for MRSA) and piperacillin-tazobactam (for Pseudomonas and anaerobes).
Empiric therapy is designed to cover a wide range of potential pathogens before culture results are available, but must be de-escalated once susceptibilities are known.
3
Select the optimal targeted definitive therapy for the identified pathogen.
Intravenous cefazolin is selected, and the empiric broad-spectrum agents are safely discontinued.
Anti-staphylococcal beta-lactams (e.g., cefazolin, nafcillin) provide superior clinical outcomes, faster bacterial clearance, and lower mortality for MSSA bacteremia compared to vancomycin.

Key Concept

For methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, anti-staphylococcal beta-lactams (such as cefazolin or nafcillin) are superior to vancomycin and should be used as targeted definitive therapy to optimize patient outcomes and adhere to antimicrobial stewardship.
Question 2956Question →

Evaluate the following diagnostic test patterns evaluating the hypothalamic-pituitary-adrenal (HPA) axis and pair each biochemical profile with the most likely underlying etiology.

Click a left item, then click its matching right item

Items

Pituitary corticotroph adenoma (Cushing disease)
Ectopic ACTH-secreting tumor
Unilateral adrenal adenoma
Autoimmune adrenalitis
Chronic exogenous prednisone therapy

Matches

Show answer & explanation

Answer

The biochemical profiles correctly match the etiologies based on ACTH dependency and the presence or absence of HPA axis feedback inhibition during dynamic testing.
Proper localization of adrenal pathologies requires interpreting the negative feedback loop. ACTH-dependent hypercortisolism (high ACTH) is differentiated using high-dose dexamethasone; pituitary sources retain partial feedback sensitivity and suppress, while ectopic sources do not. ACTH-independent hypercortisolism (low ACTH) points directly to an adrenal source. In hypocortisolism, elevated ACTH indicates primary adrenal failure (Addison's), whereas suppressed ACTH points to central causes or exogenous suppression.

Step-by-Step Solution

1
Analyze the baseline ACTH and cortisol levels for each profile.
Categorizes the condition as ACTH-dependent, ACTH-independent, or a primary failure of the adrenal gland.
ACTH dependency is the primary branch point in localizing HPA axis pathology.
2
Evaluate the response to dynamic testing, such as dexamethasone suppression or cosyntropin stimulation.
Differentiates between pituitary and ectopic sources of ACTH, and confirms primary versus secondary adrenal insufficiency.
Dynamic testing assesses the integrity of the negative feedback loop and glandular responsiveness.
3
Correlate the combined static and dynamic lab findings with the specific pathophysiologic etiology.
Accurately pairs each laboratory profile with its underlying clinical diagnosis.
Each etiology possesses a unique biochemical signature.

Key Concept

Hypothalamic-Pituitary-Adrenal (HPA) axis evaluation and localization using static ACTH/cortisol levels and dynamic suppression/stimulation testing.
Estimated Time:1m 30s
Question 2957Question →

A 62-year-old man is receiving positive-pressure mechanical ventilation in the intensive care unit for acute respiratory distress syndrome. Suddenly, the ventilator alarms for high peak airway pressures. His blood pressure drops to 65/40 mm Hg, and his heart rate increases to 142/min. Oxygen saturation drops to 80%. Physical examination reveals absent breath sounds and hyperresonance to percussion over the right hemithorax, with tracheal deviation to the left.

Arrange the following steps in the most appropriate chronological order for the management of this patient's acute complication.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential order is to first disconnect the mechanical ventilator and begin manual ventilation, followed by immediate needle thoracostomy, then insertion of a definitive thoracostomy tube, and finally obtaining a portable chest radiograph.
This sequence strictly follows the resuscitation protocol for a mechanically ventilated patient experiencing sudden hemodynamic collapse. The immediate first step is to disconnect the ventilator and manually bag the patient, which simultaneously evaluates for equipment failure and relieves potential auto-PEEP. If tension pneumothorax is clinically diagnosed (based on unilateral absent breath sounds and tracheal deviation), immediate decompression via needle thoracostomy is indicated to restore venous return and cardiac output. This temporary measure is then followed by the placement of a definitive thoracostomy tube. Finally, only after the patient is stabilized and the tube is secured should a portable chest radiograph be obtained to verify proper placement and lung re-expansion.

Step-by-Step Solution

1
Disconnect the mechanical ventilator and manually ventilate.
Rules out equipment failure and treats potential auto-PEEP.
Sudden high peak pressures and hypotension in a ventilated patient can be caused by breath-stacking (auto-PEEP); disconnecting the circuit immediately relieves this.
2
Perform immediate needle thoracostomy.
Relieves intrapleural pressure and restores venous return.
If disconnecting the ventilator does not improve hemodynamics and focal signs (tracheal deviation, unilateral absent breath sounds) remain, tension pneumothorax is the clinical diagnosis and requires emergent decompression.
3
Insert a definitive right-sided thoracostomy tube.
Provides continuous drainage of the pleural space.
Needle decompression is only a temporizing measure. A chest tube is required to fully evacuate the pneumothorax and prevent re-accumulation.
4
Obtain a portable chest radiograph.
Confirms proper tube placement and lung re-expansion.
Radiographic confirmation is necessary after the patient is stabilized to ensure the intervention was successful and the tube is correctly positioned.

Key Concept

Management algorithm for a crashing mechanically ventilated patient with suspected tension pneumothorax.
Question 2958Question →

A series of patients undergo evaluation for various nephritic and nephrotic syndromes. Based on the underlying pathophysiologic mechanisms, match each specific glomerular disease with its characteristic defining renal biopsy finding.

Click a left item, then click its matching right item

Items

Poststreptococcal glomerulonephritis
IgA nephropathy
Membranous nephropathy
Minimal change disease
Goodpasture syndrome

Matches

Show answer & explanation

Answer

The correct matches align each specific glomerular pathology with its classic immunofluorescence or electron microscopy pattern: Poststreptococcal glomerulonephritis pairs with subepithelial 'humps'; IgA nephropathy pairs with mesangial immune deposition; Membranous nephropathy pairs with subepithelial 'spikes'; Minimal change disease pairs with podocyte effacement; and Goodpasture syndrome pairs with linear IgG deposition.
Each glomerular disease has a unique pathophysiology that dictates its presentation on renal biopsy. Poststreptococcal glomerulonephritis features subepithelial humps due to heavy immune complex deposition. IgA nephropathy is characterized specifically by mesangial IgA immune deposits. Membranous nephropathy displays a 'spike and dome' pattern secondary to subepithelial deposits and subsequent basement membrane thickening. Minimal change disease shows normal light microscopy but diffuse podocyte effacement on electron microscopy. Goodpasture syndrome is an autoimmune disease driven by anti-GBM antibodies, leading to a smooth, linear immunofluorescence pattern rather than a granular one.

Step-by-Step Solution

1
Categorize each glomerular disease into its primary clinical presentation (nephritic versus nephrotic).
Poststreptococcal, IgA nephropathy, and Goodpasture syndrome are typically nephritic. Membranous nephropathy and Minimal change disease are typically nephrotic.
Establishing the clinical syndrome helps narrow down the expected pathophysiologic mechanisms.
2
Identify the type of immune complex deposition or structural damage associated with each disease.
Poststreptococcal = circulating immune complexes (granular, humps); IgA = mesangial complexes; Membranous = in situ subepithelial complexes (spikes); Minimal change = podocyte cytokine damage (effacement); Goodpasture = anti-GBM antibodies (linear).
The precise location and nature of the immune attack or structural damage directly correlate with the biopsy findings.
3
Map the pathophysiologic mechanisms to the provided microscopic descriptions.
Each disease is successfully matched to its pathognomonic biopsy feature.
Ensures accurate correlation of theoretical pathogenesis with practical diagnostic pathology.

Key Concept

Pathological evaluation of glomerular diseases relies on identifying specific patterns of immune complex deposition (linear vs. granular, subepithelial vs. mesangial), cellular proliferation, and ultrastructural podocyte changes on biopsy.
Estimated Time:1m 30s
Question 2959Question →

A 5656-year-old man comes to the clinic reporting profound fatigue, generalized weakness, and feeling cold all the time for the past 33 weeks. He has a history of metastatic melanoma and has been receiving ipilimumab therapy for the past 44 months. He reports poor appetite but has not lost significant weight. Blood pressure is 98/60 mm Hg98/60\text{ mm Hg} and pulse is 58/min58\text{/min} with no orthostatic changes. Physical examination shows pale skin without hyperpigmentation and delayed relaxation of the deep tendon reflexes. Laboratory studies show the following:

Serum sodium: 138 mEq/L138\text{ mEq/L}
Serum potassium: 4.1 mEq/L4.1\text{ mEq/L}
Serum thyroid-stimulating hormone (TSH): 1.1 mU/L1.1\text{ mU/L} (normal: 0.4–4.0 mU/L0.4\text{--}4.0\text{ mU/L})
Serum free thyroxine (T4): 0.5 ng/dL0.5\text{ ng/dL} (normal: 0.8–1.8 ng/dL0.8\text{--}1.8\text{ ng/dL})

Which of the following is the most likely underlying mechanism for this patient's current presentation?

Show answer & explanation

Answer: Lymphocytic infiltration of the anterior pituitary gland

Answer

The correct answer identifies lymphocytic infiltration of the anterior pituitary gland (hypophysitis) as the mechanism.
The correct answer identifies lymphocytic infiltration of the anterior pituitary gland, which is the underlying mechanism of hypophysitis. This patient is being treated with ipilimumab, a CTLA-4 immune checkpoint inhibitor that carries a high risk of immune-related adverse events, particularly hypophysitis. Inflammation of the pituitary gland leads to decreased secretion of anterior pituitary hormones, including thyroid-stimulating hormone (TSH) and adrenocorticotropic hormone (ACTH). The laboratory pattern of a low free T4 combined with a non-elevated (inappropriately normal) TSH is the classic hallmark of central hypothyroidism. Furthermore, the patient's hypotension and profound fatigue point to concurrent central adrenal insufficiency. Crucially, because aldosterone production is regulated by the renin-angiotensin-aldosterone system rather than ACTH, the patient's potassium levels remain normal, and the lack of elevated ACTH means there is no skin hyperpigmentation.

Step-by-Step Solution

1
Analyze the patient's thyroid laboratory results.
The patient has a low free T4 (0.5 ng/dL0.5\text{ ng/dL}) with an inappropriately normal TSH (1.1 mU/L1.1\text{ mU/L}).
This combination indicates a central (secondary) etiology for the hypothyroidism, as a primary thyroid problem would result in an elevated TSH due to the lack of negative feedback.
2
Correlate the central hypothyroidism with the patient's symptoms and medication history.
The patient is taking ipilimumab, an immune checkpoint inhibitor known to cause immune-related adverse events.
Ipilimumab specifically has a high risk of inducing hypophysitis (lymphocytic infiltration of the pituitary gland), leading to anterior pituitary hormone deficiencies.
3
Evaluate the remaining symptoms and lab values to confirm the diagnosis.
The patient has hypotension and fatigue (suggesting adrenal insufficiency), but normal sodium and potassium levels without hyperpigmentation.
Central adrenal insufficiency (due to low ACTH from hypophysitis) preserves aldosterone secretion because aldosterone is primarily regulated by the renin-angiotensin-aldosterone system, thereby keeping potassium levels normal and preventing severe hyponatremia.

Key Concept

Immune checkpoint inhibitor-induced hypophysitis typically presents with central hypothyroidism (low free T4, normal/low TSH) and central adrenal insufficiency (low cortisol, normal electrolytes).
Estimated Time:1m 15s
Question 2960Question →

Paramedics bring a 24-year-old woman to the resuscitation bay due to an intractable respiratory crisis. The patient's roommate reports that she has a long-standing history of asthma and has been using her rescue inhaler excessively over the past three hours with no improvement. On initial assessment, the patient is visibly exhausted, diaphoretic, and exhibits a decreased level of consciousness. Vital signs are temperature 37.2°C (99.0°F), pulse 135/min, blood pressure 110/65 mm Hg, and respirations 34/min. Pulse oximetry is 86% on room air. Auscultation of the lungs reveals markedly decreased breath sounds bilaterally with no audible wheezing.

An arterial blood gas analysis on room air reveals the following:

ParameterValue
pH7.28
PaCO2_252 mm Hg
PaO2_258 mm Hg
HCO3−_3^-24 mEq/L

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Endotracheal intubation and mechanical ventilation

Answer

Endotracheal intubation and mechanical ventilation
This patient is presenting with a severe asthma exacerbation complicated by impending respiratory failure. In a typical mild-to-moderate asthma exacerbation, hyperventilation leads to a low PaCO2 (respiratory alkalosis). However, as respiratory muscles fatigue, airway resistance increases, and alveolar ventilation plummets, the PaCO2 normalizes and eventually becomes elevated, causing a respiratory acidosis. The combination of a 'silent chest' (absent wheezing due to severely restricted airflow), a PaCO2 of 52 mm Hg, and a decreased level of consciousness are classic signs of exhaustion and imminent respiratory arrest. When a patient with respiratory failure develops an altered mental status, they lose the ability to protect their airway and cannot cooperate with noninvasive ventilation. Therefore, immediate endotracheal intubation and mechanical ventilation is the definitive and most appropriate next step to secure the airway and ensure adequate gas exchange.

Step-by-Step Solution

1
Analyze the patient's clinical signs and physical examination findings.
The patient exhibits exhaustion, altered mental status, and a 'silent chest' (absent wheezing with poor air entry).
These are clinical hallmarks of severe respiratory muscle fatigue and critically impaired airflow in an asthma exacerbation.
2
Interpret the arterial blood gas (ABG) values.
The ABG shows a primary respiratory acidosis (pH 7.28, PaCO2 52 mm Hg) along with hypoxemia.
During an early asthma attack, hyperventilation typically causes a low PaCO2 (respiratory alkalosis). A normal or elevated PaCO2 indicates that the patient can no longer maintain the work of breathing, signaling impending respiratory failure.
3
Determine the most appropriate intervention based on the clinical status.
Immediate endotracheal intubation and mechanical ventilation is selected.
Because the patient has a decreased level of consciousness, she cannot protect her airway or cooperate with noninvasive positive pressure ventilation, making intubation the only safe option.

Key Concept

Management of impending respiratory failure in severe asthma exacerbations.
PreviousPage 148 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 148 | Examkin